Table 1.
Clinical characteristics of patients included in study.
| Clinical Parameters | Total N = 52 (%) |
|---|---|
| Age range | 28–79 (Median = 53 years) |
| FIGO Stage | |
| IB2 | 3 (5.7%) |
| IIA | 8 (15.5%) |
| IIB | 16 (30.7%) |
| IIIA | 16 (30.7%) |
| IIIB | 4 (7.7%) |
| IVA | 3 (5.7%) |
| Clinical Outcomes/Variables | |
| Recurrence/No recurrence | 12/40 (23%/77%) |
| Distant Metastatic/Non metastatic | 15/37 (28%/72%) |
| Metastasis to Lung/Other sites | 5/10 (9%/19%) |
| Lymph node Present/Absent | 15/37 (28%/72%) |
| Paraaortic lymph node/Pelvic node | 2/13 (3.8%/25%) |
| Mean follow up | 29.9 months |
| Median follow up | 28.5 months |
| Mean recurrence interval | 18.5 months |